600252 Guangxi Wuzhou Zhongheng Group
- 1.90
- +0.02+1.06%
About Guangxi Wuzhou Zhongheng Group Company
The company was founded in 1993 and listed on the Shanghai Stock Exchange in 2000. It is controlled by Guangxi Investment Group Co., Ltd., the first “Fortune 500” enterprise in Guangxi, and itself controls 28 participating companies. It is one of the top 100 Chinese medicine enterprises, the top 100 Chinese medicine enterprises, and the second batch of pilot enterprises for the integrated development of advanced manufacturing and modern service industries in the country. The company has pharmaceutical manufacturing as its core leading industry, and its business covers fields such as pharmaceutical manufacturing, health consumption, pharmaceutical research and development, traditional Chinese medicine resources, Japanese cosmetics, and pharmaceutical distribution. The main products include injectable thrombotron (freeze-dried), Zhonghua Damping Pills, Gynecomasite Tablets, Yanjianning Pills, Angong Niuhuang Pills, Snake Tan Chuanbei Liquid, Fluorescein Sodium Injection, etc., and owns famous trademarks such as “Zhonghua” and “Morning Bell.” Company Honors: National High-tech Enterprise, National Intellectual Property Demonstration Enterprise, ranked among the top 100 Chinese pharmaceutical industry and the top 100 Chinese medicine companies, selected as the country's second batch of advanced manufacturing and modern service industry integrated development pilot enterprises, “Guangxi Double Hundred Action” enterprises, “Excellent Pharmaceutical Product Brands in China's Chemical Pharmaceutical Industry”, “Single Champion Product in Manufacturing (2019-2021)”, “2021 China Industry-University-Research Cooperation Innovation and Promotion Award”, and “Chinese Time-honored Brand”.
Company Profile
Company Executives
- Name
- Position
- Salary
- jinhai yang
- Chairman, Directors, Chairman of the Strategy Committee, Nomination Committee Members
- --
- shiyue xu
- Directors, Member of the Risk Control and Compliance Committee, Member of the Strategy Committee, Member of the Remuneration and Assessment Committee, Audit Committee Member
- --
- hairun wang
- Directors, Audit Committee Member, Chairman of the Risk Control and Compliance Committee, Member of the Strategy Committee, Member of the Remuneration and Assessment Committee
- --
- hu chen
- Directors, Member of the Risk Control and Compliance Committee
- --
- junhua li
- Independent Directors, Chairman of the Audit Committee, Member of the Remuneration and Assessment Committee, Member of the Risk Control and Compliance Committee, Nomination Committee Members
- 120.00K
- daofeng chen
- Independent Directors, Member of the Strategy Committee, Chairman of the Nomination Committee, Member of the Remuneration and Assessment Committee, Audit Committee Member
- 40.00K
- xingchu gong
- Independent Directors, Audit Committee Member, Chairman of the Remuneration and Assessment Committee, Nomination Committee Members, Member of the Risk Control and Compliance Committee
- 40.00K
- xiangyong wang
- Board Secretary, General Counsel
- 1.02M
- kunshi wang
- Securities Affairs Representative
- --
- mingliang liu
- Chairman of the Supervisory Board, Shareholder Supervisors
- 980.40K
- jian wang
- Auditors
- --
- weimin peng
- Deputy General Manager
- 1.53M
- tianjiao wang
- Deputy General Manager
- --
- lin xiao
- Deputy General Manager
- 1.13M
- ming chen
- Deputy General Manager
- 1.55M
- hui ge
- Head of Finance
- 217.50K
- jian liang
- Employee Supervisors
- 268.40K
Analysis
Price Target
No Data
No Data